A vaccine for rotavirus

Article Abstract:

The FDA has approved a vaccine against rotavirus. Sold under the trade name RotaShield, the vaccine is 70% to 90% effective in preventing rotavirus infection when given as three separate shots at two, four and six months of age. The US Advisory Committee on Immunization Practices (ACIP) recommends adding this vaccine to the routine vaccination schedule given to all children in their first year of life. Rotavirus infections are a common cause of diarrhea and dehydration in young children.

Product introduction, Prevention, Rotavirus infections, RotaShield (Vaccine)

---

Pneumococcal vaccine

Article Abstract:

Pneumococcal vaccine can be given at the same time as influenza vaccine. Many pneumococcal bacteria are becoming resistant to antibiotics, so it is especially important to vaccinate the elderly. Young children with chronic diseases or immunodeficiency may also benefit. The vaccine is about 60% to 80% effective in preventing infection with pneumococcal bacteria.

Evaluation, Pneumococcal vaccine, Pneumococcal vaccines

---

Similar abstracts:

• Abstracts: Lyme disease vaccine. Infliximab (Remicade) for Crohn's disease. Pramipexole and ropinirole for Parkinson's disease
• Abstracts: Puumala virus infections in Finland: increased occupational risk for farmers. Occupational status and cardiovascular disease risk factors in the rapidly developing, high-risk population of Mauritius
• Abstracts: HIV-1 and HTLV-I in sexually transmitted disease clinics in the Dominican Republic. Physical and emotional problems of elite female gymnasts
• Abstracts: The science of creatine enhancement. 6 creatine fears: real concern or false alarm? Time consuming
• Abstracts: Medical, Legal, and Societal Implications of Androstenedione Use. Creatine and androstenedione -- two "dietary supplements."

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.